Disulfiram (High-Dose) for Lyme
Off-label use of alcoholism drug (Antabuse) at high doses to kill Borrelia persisters.
74/100
Kenneth Liegner, Brian Fallon
6-18 months, sometimes longer
10 phases
3 targeted
Protocol Overview
Off-label use of alcoholism drug (Antabuse) at high doses to kill Borrelia persisters. Emerging as most effective treatment for chronic Lyme. Requires careful monitoring.
Conditions Treated
Key Resources
Safety Profile
Game-changer in Lyme treatment according to many patients. Discovered by Stanford screen. Kills persister forms of Borrelia that other antibiotics miss. Can cause severe side effects (neuropathy, psychosis). Requires close monitoring. Many Lyme patients report sustained remission after years of suffering. Off-label use, not FDA-approved for Lyme. Most exciting Lyme treatment in years.
About Evidence Score
The Evidence Score rates the strength of clinical and scientific evidence behind this protocol. Higher scores indicate stronger research support. This is a research tool, not medical advice.
Educational purposes only. Some alternative protocols carry serious risks. Always consult qualified healthcare professionals before beginning any treatment.